CGM increased time spent in normoglycaemia and reduced severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia, compared with SMBG. Our results support the concept of using CGM in this high-risk population (The Lancet Diabetes & Endocrinology)
Diabetes News
Tag: CGM
Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift
This pilot study affirms the efficacy of GEM and further suggests that GEM intervention may be augmented with CGM to provide continuous and immediate feedback about the consequences of one’s food and activity choices on glucose levels (BMJ Open, Diabetes Research & Care)
Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study
The observed interference with glucose measurements in the tested CGM devices coincided temporally with appearance of acetaminophen in the ISF. The method applied here can be used to determine the susceptibility of current and future CGM systems to interference from acetaminophen or other exogenous pharmacologic agents (Diabetes Technology and Therapeutics)
High Incidence of Hypoglycemia in Stable Insulin-Treated Type 2 Diabetes Mellitus: Continuous Glucose Monitoring vs. Self-Monitored Blood Glucose
In stable well-controlled, insulin-treated patients with type 2 diabetes, CGM showed higher numbers of hypoglycemic events than did SMBG, especially at night. CGM is a useful tool that provides clinically valuable information about glucose control in these patients (Canadian Journal of Diabetes)
Glycosmedia is also available as an App: